The omics lab services market is set to grow significantly, increasing from $75.1 billion in 2026 to $189.5 billion by 2036, fueled by a 9.7% CAGR, with drug discovery being a primary driver. Key players like Thermo Fisher, Illumina, and QIAGEN are focusing on enhancing sequencing capabilities and integrating bioinformatics services. The USA, Japan, and Germany are leading in growth, with a notable demand for high-quality genomic data and efficient sample processing. However, challenges such as sample quality and data privacy remain. The report provides essential insights for stakeholders in the market to strategize and optimize their operations.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.factmr.com/media-release/2197/omics-lab-services-market
